Daptomycin recalls

The FDA has published 9 recalls involving Daptomycin since 2016. The latest was reported on 9 Sep 2026. Most were for manufacturing (cgmp) deviations. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls9since 2016

Last 12 months2reported

Class I222% of total

Ongoing2latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 2 0

Severity split

Class I 2 22%Class II 7 78%Class III 0 0%

Why daptomycin is recalled

Companies

Accord Healthcare333%
Baxter Healthcare222%
Mylan Institutional111%
Redline Pharmacy Solutions111%
Pfizer111%
Baptist Health Medical Towers Pharmacy and Infusion Services111%

By year

2026222%
2023333%
2020222%
2018111%
2016111%

Ongoing daptomycin recalls

2 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg recalled	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg recalled	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide

All daptomycin recalls, newest first

9 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg recalled	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg recalled	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
8 Mar 2023Drug	CLASS II	Daptomycin for Injection 350 mg/vial recalled by Accord HealthcareDaptomycin	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Daptomycin for Injection 500 mg per vial, Single-dose vial recalledDaptomycin	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
25 Jan 2023Drug	CLASS I	Daptomycin for Injection 350 mg/vial-dose vial recalled	Accord Healthcare	Packaging Defects	Nationwide
12 Aug 2020Drug	CLASS I	Daptomycin for Injection, 500 mg/vial, Single-Dose Vial recalledDaptomycin	Mylan Institutional	Particulate Matter	Nationwide
18 Mar 2020Drug	CLASS II	Daptomycin, 500MG in 0.9% NACL Injectable Redline Specialty recalled	Redline Pharmacy Solutions	Other	NE
8 Aug 2018Drug	CLASS II	Daptomycin for Injection, 500 mg per vial, packaged as-dose vial recalled	Pfizer	Sterility	Nationwide
8 Jun 2016Drug	CLASS II	Daptomycin 650 mg in 0.9% NS, FOR IV USE ONLY recalled	Baptist Health Medical Towers Pharmacy and Infusion Services	Sterility	AR

Should you stop taking Daptomycin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.